With $375 million total raised, Orchard will spend about $90 million to fund Orchard’s 150,000-square-foot manufacturing site in Fremont, California. The site won’t be running until 2021, and Orchard plans to continue working with CMOs to make its treatments. Source: Fierce Biotech 11/01/2019.